BioSpace News Archive

Policy

U.S. and China Edge Toward Agreement on Audits Amidst Delisting Threats

U.S. and Chinese regulators are edging toward a cooperation plan on Chinese companies that have stock listed on U.S. stock exchanges.

March 17, 2022
·
3 min read
·
Mark Terry
Business

BioSpace Movers & Shakers: Enveda, Evaxion, Elevation

Biopharma and life sciences companies continue to strengthen their executive teams and boards with this week’s Movers & Shakers.

March 17, 2022
·
7 min read
·
Alex Keown
Drug Development

Intranasal COVID Vaccine Offers Hope Against Subvariants

Codagenix is entering the vaccine arena with a possible new frontrunner in protection: CoviLiv. It’s an intranasal COVID vaccine that provides hope against subvariants.

March 17, 2022
·
3 min read
·
Hayley Shasteen
Drug Development

Peginterferon Lambda Could be New Weapon Against COVID-19 Hospitalization, Deaths

Eiger BioPharmaceuticals announced that its COVID-19 therapeutic, Peginterferon Lambda reduced the risk of hospitalization and emergency room visits by 50%.

March 17, 2022
·
3 min read
·
Hayley Shasteen
The Missing Piece: CPOs are Bringing Patients’ Voices to the Table

Biopharma is heeding the call and many pharmaceutical companies are working towards including patient communities in their work.

March 17, 2022
·
6 min read
·
Hayley Shasteen
Business

AstraZeneca May Abandon US Regulatory Efforts for COVID-19 Vaccine

Sir Mene Pangalos said the company was considering not submitting it to the FDA if it finds it is “banging its head against a brick wall indefinitely.”

March 17, 2022
·
2 min read
·
Mark Terry
Career Advice

How to Know if Remote Work is Right for You

Just because everyone around you seems to be switching to a work-from-home position does not mean it is the right decision for you. It’s important to weigh the options carefully before you decide.

March 17, 2022
·
5 min read
·
Kaley Lefevre
Innate Pharma Announces Conference Call and Webcast for Full Year 2021 Financial Results

Innate Pharma SA, announced that the Company will hold a conference call on Thursday, March 24, 2022 at 2 p.m. CET / 9 a.m. ET.

March 17, 2022
·
4 min read
Drug Development

Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients

RELIEF THERAPEUTICS Holding SA announced that its wholly owned subsidiary, APR Applied Pharma Research SA, reported final data from its clinical trial of nasal spray, Sentinox, in SARS-CoV-2 infected patients.

March 17, 2022
·
6 min read
Sensorion Update on SENS-401

Sensorion provides an update following supplementary analysis of the 115-patient Phase 2 AUDIBLE-S study of SENS-401 for the treatment of sudden sensorineural hearing loss.

March 17, 2022
·
7 min read